Diadema Partners LP Gossamer Bio, Inc. Transaction History
Diadema Partners LP
- $328 Billion
- Q2 2025
A detailed history of Diadema Partners LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 824,800 shares of GOSS stock, worth $1.9 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
824,800
Previous 269,589
205.95%
Holding current value
$1.9 Million
Previous $297 Million
242.1%
% of portfolio
0.31%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
148Shares Held
161MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$42.2 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$41.6 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$26.2 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$18.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$16.4 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $216M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...